| 0 (0%) | 05-01 17:50 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 11.1 | 1-year : | 11.3 |
| Resists | First : | 9.5 | Second : | 9.68 |
| Pivot price | 9.32 | |||
| Supports | First : | 9.22 | Second : | 7.67 |
| MAs | MA(5) : | 9.32  |
MA(20) : | 9.35 |
| MA(100) : | 9.49  |
MA(250) : | 9.25 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 51 |
D(3) : | 39.6 |
| RSI | RSI(14): 45.1 |
|||
| 52-week | High : | 9.75 | Low : | 8.05 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ IQI ] has closed below upper band by 24.5%. Bollinger Bands are 54.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 9.39 - 9.43 | 9.43 - 9.48 |
| Low: | 9.21 - 9.27 | 9.27 - 9.32 |
| Close: | 9.28 - 9.36 | 9.36 - 9.43 |
Wed, 06 Mar 2024
Clinical outcomes of patients with lymphoid blastic phase of chronic myeloid leukemia treated with CAR T-cell therapy ... - Nature.com
Fri, 19 Jan 2024
Volatile organic compounds (VOCs) emissions from internal floating-roof tank in oil depots in Beijing: Influencing ... - ScienceDirect.com
Tue, 12 Dec 2023
Coinfusion of Cord Blood and Haploidentical Grafts May Improve Outcomes in AML - Hematology Advisor
Fri, 24 Nov 2023
Whole-transcriptome analysis after the acquisition of antibiotic resistance of Cronobacter sakazakii: Mechanisms of ... - ScienceDirect.com
Sat, 28 Oct 2023
COLUMN: Local pharmacist offers health tips for seniors - OrilliaMatters
Fri, 01 Sep 2023
Experimental study on crack irregularity of hollow shell particle under impact loading - ScienceDirect.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 53 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 33.6 (%) |
| Shares Short | 50 (K) |
| Shares Short P.Month | 36 (K) |
| EPS | -0.01 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 10.63 |
| Profit Margin | -1.6 % |
| Operating Margin | 87 % |
| Return on Assets (ttm) | 2.4 % |
| Return on Equity (ttm) | -0.2 % |
| Qtrly Rev. Growth | -1 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0.77 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 80 (M) |
| Levered Free Cash Flow | 15 (M) |
| PE Ratio | -936 |
| PEG Ratio | 0 |
| Price to Book value | 0.88 |
| Price to Sales | 12.02 |
| Price to Cash Flow | 6.22 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|